Literature DB >> 14619631

Retinoblastoma in Uzbekistan.

T Mouratova1.   

Abstract

Retinoblastoma incidence and mortality rates associated with age, sex, and ethnic background between 1978 and 1999 have been studied. Statistical analysis of normal and standardised incidence rates was performed on 972 patients. For 21 years, annual retinoblastoma incidence for both sexes has increased. There was no difference in cumulative retinoblastoma incidence between males and females. Among all ethnic groups living in Uzbekistan, the highest retinoblastoma incidence occurred among Tartars and Uzbeks who frequently marry their family members. There was no difference in mortality of males and females. Over a 5-year period from the moment of diagnosis, almost every third child with retinoblastoma died of metastases. Most of retinoblastoma cases were represented by patients with late diagnosis. Before 1978, there was no information in Uzbekistan about the number of patients with malignant eye tumours, including retinoblastoma.

Entities:  

Mesh:

Year:  2003        PMID: 14619631

Source DB:  PubMed          Journal:  Bull Soc Belge Ophtalmol        ISSN: 0081-0746


  4 in total

1.  Retinoblastoma in Taiwan: survival rate and prognostic factors.

Authors:  Chia-Yau Chang; Tzeon-Jye Chiou; Betau Hwang; Li-Yuan Bai; Wen-Ming Hsu; Yuh-Lin Hsieh
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

Review 2.  Current management strategies for intraocular retinoblastoma.

Authors:  Jonathan W Kim; David H Abramson; Ira J Dunkel
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Retinoblastoma in the democratic republic of congo: 20-year review from a tertiary hospital in kinshasa.

Authors:  Aimé Kazadi Lukusa; Michel Ntetani Aloni; Bertin Kadima-Tshimanga; Moïse Mvitu-Muaka; Jean Lambert Gini Ehungu; René Ngiyulu; Pépé Ekulu Mfutu; Aléine Budiongo Nzazi
Journal:  J Cancer Epidemiol       Date:  2012-04-26

4.  Clinicopathological Findings of Retinoblastoma: A 10-Year Experience from a Tertiary Hospital in Kampala, Uganda.

Authors:  James Joseph Yahaya; Belson Rugwizangoga; Alex Mremi; Asafu Munema
Journal:  J Ophthalmol       Date:  2019-06-16       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.